agilon health, inc.
AGL
$3.51
-$0.02-0.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 44.20% | 27.72% | 38.64% | 52.04% | 185.24% |
| Total Other Revenue | 27.99% | -5.02% | 69.01% | 164.79% | 482.30% |
| Total Revenue | 44.16% | 27.63% | 38.69% | 52.17% | 185.59% |
| Cost of Revenue | 35.61% | 37.73% | 42.98% | 55.86% | 219.07% |
| Gross Profit | 59.68% | -274.18% | -41.05% | 2.69% | -1,145.95% |
| SG&A Expenses | -7.39% | -14.42% | -13.26% | 6.39% | 1.01% |
| Depreciation & Amortization | 37.15% | 52.59% | 38.05% | 97.83% | 616.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.33% | 34.59% | 38.90% | 52.71% | 187.93% |
| Operating Income | 36.30% | -236.07% | -46.69% | -887.27% | -203.89% |
| Income Before Tax | 37.27% | -461.82% | -102.27% | -61.99% | -307.77% |
| Income Tax Expenses | 558.05% | -148.76% | -61.14% | 92.44% | -53.32% |
| Earnings from Continuing Operations | 36.32% | -428.30% | -91.33% | -67.37% | -302.79% |
| Earnings from Discontinued Operations | 101.01% | 87.47% | -- | -254.48% | -320.79% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -- | -143.48% | -147.62% | -38.55% |
| Net Income | 54.09% | -274.14% | -83.19% | -137.85% | -308.09% |
| EBIT | 36.30% | -236.07% | -46.69% | -887.27% | -203.89% |
| EBITDA | 38.48% | -257.30% | -41.12% | -77.45% | -190.22% |
| EPS Basic | 54.72% | -268.77% | -82.84% | -138.14% | -310.80% |
| Normalized Basic EPS | 40.12% | -448.44% | -96.92% | -34.38% | -312.38% |
| EPS Diluted | 54.54% | -251.62% | -78.04% | -143.40% | -311.45% |
| Normalized Diluted EPS | 40.12% | -448.44% | -96.92% | -33.06% | -312.38% |
| Average Basic Shares Outstanding | 1.37% | 1.43% | 0.23% | -1.02% | -0.41% |
| Average Diluted Shares Outstanding | 1.37% | 1.43% | 0.23% | -3.08% | -0.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
